References
- Gottfries C G, Adolfsson R, Aquilonius S-T, Carlsson A, Eckernäs S-Å, Nordberg A, Oreland L, Svennerholm L, Wiberg Å, Winblad B. Biochemical Changes in Dementia Disorders of Alzheimer Type (AD/SDAT). Neurobiol Aging 1983; 4: 261–71
- Arai H, Kosaka K, Tizuka R. Changes of biogenic amines and their metabolites i postmortem brains from patients with Alzheimer-type dementia. J Neurochem 1984; 43: 388–93
- Hyttel J. Citalopram - Pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog Neuro-Psychopharmacol & Biol Psychiatry 1982; 6: 277–95
- Gottlieb P, Wandall T, Fredricson Overö K. Initial, clinical trial of a new, specific 5-HT re-uptake inhibitor, citalopram (Lu 10–171). Acta Psychiatr Scand 1980; 62: 236–44
- Pedersen O, Krag-Sörensen P, Bjerre M, Fredricson Overö K, Gram L F. Citalopram, a selective serotonin re-uptake inhibitor: clinical antidepressive and long-term effect — a phase II study. Psychopharmacology 1982; 77: 199–204
- Gastpar M, Gastpar G. Preliminary studies with citalopram (Lu 10–171), a specific 5-HT-re-uptake inhibitor, as antidepressant. Prog Neuro-Psychopharmacol & Biol Psychiat 1982; 6: 319–25
- Öfsti E. Citalopram — a specific 5-HT-re-uptake inhibitor — as an antidepressant drug: a phase II multicentre trial. Prog Neuro-Psychopharmacol & Biol Psychiatry 1982; 6: 327–35
- Bråne G, Gottfries C G (1985) Treatment with monoaminergic drugs in Alzheimer's disease and senile dementia. Normal aging. Alzheimer's disease and senile dementia. Aspects on etiology, pathogenesis diagnosis and treatment. Proceedings of two symposia held at The CINP 14th Congress, FlorenceItaly, June, 22–231984, C G Gottfries. L'Université de Bruxelles, Bruxelles, 279–86
- Harenko A, Elgen K. On a clinical phase II study of citalopram in elderly depressed patients. 1984, Copenhagen: H. Lundbeck A/S Report,19/831
- Gottfries C G, Bråne G, Gullberg B, Steen G. A new rating scale for dementia syndromes. Arch Gerontol Geriatr 1982; 1: 311–30
- Andersen O, Johansson B D, Svennerholm L. Monoamine metabolites in successive samples of spinal fluid. Acta Neurol Scand 1981; 63: 247–54
- Balldin J, Gottfries C G, Karlsson I, Lindstedt G, Långström G, Wålinder J. Dexamethasone Suppression test and Serum Prolactin in Dementia Disorder. Br J Psychiatry 1983; 143: 277–81